Cargando…
Association of serum follistatin levels with histological types and progression of tumor in human lung cancer
BACKGROUND: Follistatin (FST), an activin-binding protein, inhibits activin action by interfering with activin binding to its receptor. The prognostic value of FST has been studied in various cancers. However, these studies rarely focus on lung cancer. In our study, we investigated the relationship...
Autores principales: | Zhang, Pengyu, Ruan, Yingxin, Xiao, Jun, Chen, Fangfang, Zhang, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195981/ https://www.ncbi.nlm.nih.gov/pubmed/30377409 http://dx.doi.org/10.1186/s12935-018-0664-2 |
Ejemplares similares
-
Monitoring Value of Serum HER2 as a Predictive Biomarker in Patients with Metastatic Breast Cancer
por: Zhang, Pengyu, et al.
Publicado: (2020) -
Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation
por: Henes, Melanie, et al.
Publicado: (2018) -
Follistatin Is a Novel Biomarker for Lung Adenocarcinoma in Humans
por: Chen, Fangfang, et al.
Publicado: (2014) -
Serum Activin A and Follistatin Levels in Gestational Diabetes and the Association of the Activin A-Follistatin System with Anthropometric Parameters in Offspring
por: Näf, Silvia, et al.
Publicado: (2014) -
Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer
por: Bi, Fangfang, et al.
Publicado: (2020)